Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Public ClinicalTrials.gov record NCT01694186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the safety and efficacy of an FAI insert for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye.
Study identification
- NCT ID
- NCT01694186
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 129 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2013 (Actual)
- Primary completion
- Mar 26, 2018 (Actual)
- Completion
- Mar 26, 2018 (Actual)
- Last update posted
- Apr 2, 2021
2013 – 2018
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Vitreaous Associates | Beverly Hills | California | 90211 | — |
| Retinal Consultants Medical Group, Inc | Sacramento | California | 95819 | — |
| Retina Macula Institute | Torrance | California | 90503 | — |
| Retina Consultants of Southern Colorado | Colorado Springs | Colorado | 80909 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Ophthalmology & Visual Sciences | Lexington | Kentucky | 40508 | — |
| Ocular Immunology and Uveitis Foundation | Cambridge | Massachusetts | 02142 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Retina Consultants | Slingerlands | New York | 12159 | — |
| Duke University Eye Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| OHSU Casey Eye Institute | Portland | Oregon | 97239 | — |
| Charleston Neuroscience Institute | Ladson | South Carolina | 29456 | — |
| Texas Retina Associates | Arlington | Texas | 76012 | — |
| Retina Consultants of Houston | Houston | Texas | 77030 | — |
| Foresight Studies, LLC | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01694186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2021 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01694186 live on ClinicalTrials.gov.